UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment No. 1) Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019

(Mark One)
ORQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2017
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______to______   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:000-54163COMMISSION FILE NUMBER

333-193220

 

NuLife Sciences, Inc.
(Exact name of registrant as specified in its Charter)

GULF WEST SECURITY NETWORK, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 46-3876675

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employee Identification No.)

2618 San Miguel, Suite 203

Newport Beach, CA

incorporation)
 92660(I.R.S. Employer Identification No.)
(Address of principal executive office)(Zip Code)

 

(949) 973-0684Park Tower Building, 4th Floor, Suite 4200-A, 400 East Kaliste Saloom Road

Lafayette, LA 70508-8517

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code)

Not Applicable

code: (337) 210-8790(Former Name, former address and former fiscal year, if changed since last report)

   

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuerregistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes              No      

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes              No      

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”filer,” “smaller reporting company” and “smaller reporting“emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filerAccelerated filer
Non-accelerated filer (Do not check if smaller reporting company)Smaller reporting company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes                     No      

 

Indicate the numberAs of May 20, 2019, there were 4,518,250 shares outstanding of each of the issuer’s classes ofour common stock, as of the latest practicable date: As of February 20, 2018, there were 40,504,391 shares of $0.001 par value common stock, issued and$0.001 per share, outstanding.



 

EXPLANATORY NOTE

 

The purpose of this Amendment No. 1 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended DecemberMarch 31, 2017,2019, filed with the Securities and Exchange Commission on February 23, 2018May 20, 2019 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q. No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 


NuLife Sciences, Inc.GULF WEST SECURITY NETWORK, INC.
  
Date: March 27, 2018By: /s/  Fred Luke
Fred Luke
President
(Duly Authorized Officer and Principal Executive Officer)
   
Date: May 23, 2019By:/s/ Louis J. Resweber
Louis J. Resweber
President (Principal Executive Officer)